Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2005
02/15/2005US6855319 Gene encoding merozoite protein of Babesia caballi, recombinant protein obtained therefrom and utilization thereof
02/15/2005US6855318 Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
02/15/2005US6855317 Immunological herpes simplex virus antigens and methods for use thereof
02/15/2005US6855316 Combination of an adjuvant and an isolated p42 polypeptide comprising at least a portion of the 42 kDa C-terminal processing fragment of major merozoite surface protein gp195 from a Plasmodium falciparum isolate
02/15/2005US6855314 Particle containing a vector comprising a nucleic acid inserted between a pair of adeno-associated virus inverted terminal repeats used to deliver the nucleic acid to alveolar acid cells
02/15/2005US6855277 Method and apparatus for liposome production
02/15/2005US6855132 Apparatus with weeping tip and method of use
02/15/2005CA1341473C Regeneration of graminaceous plants of the subfamily pooideae from protoplasts
02/14/2005WO2005024025A1 Polyene polyketides and methods of production
02/10/2005WO2005012576A2 Molecular markers for the selection of soybean plants having superior agronomic performance
02/10/2005WO2005012562A1 Screening assay for anti-bacterial compounds
02/10/2005WO2005012559A1 Methods of using a sterol biosynthesis pathway reporter gene to screen for antifungal or lipid lowering compounds
02/10/2005WO2005012546A2 Methods for isolating and identifying novel target-specific structuremers for use in the biological sciences
02/10/2005WO2005012539A1 Vaccination vectors derived from lymphotropic human herpes viruses 6 and 7
02/10/2005WO2005012537A2 Adenoviral vector-based vaccines
02/10/2005WO2005012536A1 Method of efficiently constructing growth regulatory recombinant adenovirus vector and kit for the construction thereof
02/10/2005WO2005012535A2 Method for producing life attenuated viruses and use of viral particles thus produced.
02/10/2005WO2005012534A1 Expression systems for insect pest control
02/10/2005WO2005012533A2 Genotoxicity testing
02/10/2005WO2005012532A1 System for the production of dimeric proteins based on the transport system of hemolysin of escherichia coli
02/10/2005WO2005012531A2 Antibody cdr polypeptide sequences with restricted diversity
02/10/2005WO2005012530A2 Antagonists and agonists of ldcam and methods of use
02/10/2005WO2005012529A1 Plant producing hyaluronic acid
02/10/2005WO2005012528A1 A method of preparing epitopes chimeric gene vaccine
02/10/2005WO2005012527A1 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
02/10/2005WO2005012526A1 Lafora's disease gene
02/10/2005WO2005012525A1 Short interfering rna as an antiviral agent for hepatitis c
02/10/2005WO2005012524A1 Use of rnai inhibiting parp activtiy for the manufacture of a medicament for the treatment of cancer
02/10/2005WO2005012523A1 Methods and compositions for isolating small rna molecules
02/10/2005WO2005012522A1 Clean-up beads
02/10/2005WO2005012521A1 Nucleic acid isolation
02/10/2005WO2005012520A1 Gene imparting redifferentiation ability of plant and utilization of the same
02/10/2005WO2005012519A1 Transposon transferase and use thereof
02/10/2005WO2005012517A2 Use of the fret phenomenon for in vivo follow-up of biological events
02/10/2005WO2005012516A2 Maize cellulose synthases and uses thereof
02/10/2005WO2005012515A2 Novel glyphosate-n-acetyltransferase (gat) genes
02/10/2005WO2005012497A2 Translocation tagging
02/10/2005WO2005012496A2 Novel nucleic acids from sesame plants
02/10/2005WO2005012495A2 Methods for expression and purification of immunotoxins
02/10/2005WO2005012491A2 Surface expression of biologically active proteins in bacteria
02/10/2005WO2005012487A2 Compositions and methods for preparing short rna molecules and other nucleic acids
02/10/2005WO2005012486A2 Metabolically engineered bacterial strains having enhanced 2-keto-d-gluconate accumulation
02/10/2005WO2005012483A2 Vpr selective rnai agents and methods for using the same
02/10/2005WO2005012407A2 Polymer encapsulation of adenoviruses
02/10/2005WO2005012360A2 Binding molecules against sars-coronavirus and uses thereof
02/10/2005WO2005012359A2 Anti-vegf antibodies
02/10/2005WO2005012357A1 Bcl-2 splicing variants
02/10/2005WO2005012354A1 Method for extending the half-life of fviii
02/10/2005WO2005012351A2 Novel functions for decay accelerating factor (daf) in inflammation
02/10/2005WO2005012344A1 Adipocyte complement related protein zacrp11
02/10/2005WO2005012341A2 Pichia methanolica secretory signal
02/10/2005WO2005012340A1 Nematicidal proteins
02/10/2005WO2005012337A2 Antigenic peptides of sars coronavirus and uses thereof
02/10/2005WO2005012336A2 Uranium-chelating peptides and uses thereof
02/10/2005WO2005012316A2 Method for the production of multiply-unsaturated fatty acids in transgenic organisms
02/10/2005WO2005012305A2 Tricyclic parp inhibitors
02/10/2005WO2005011735A1 Antibodies and methods for generating genetically altered antibodies with enhanced effector function
02/10/2005WO2005011724A1 A method of producing an anticoagulation effect
02/10/2005WO2005011715A1 Viral vectors
02/10/2005WO2005011580A2 Compositions and methods for herpes simplex prophylaxis and treatment
02/10/2005WO2005011371A1 Method of constructing nuclear-transplanted egg, parthenogenetic embryo and parthenogenetic mammal
02/10/2005WO2005011367A1 A chloroplast transgenic approach to express and purify human serum albumin, a protein highly susceptible to proteolytic degradation
02/10/2005WO2005011366A1 Polynucleotides, polypeptides and their use in the production of plants with altered condensed tannins
02/10/2005WO2005004893A3 Inhibition of stress-induced ligand-dependent egfr activation
02/10/2005WO2004111249A3 Protein constructs containing caspase recognition sites
02/10/2005WO2004108934A8 Safe production of a product of interest in hybrid seeds
02/10/2005WO2004108906A3 Bacterial carriers for nucleotide sequences coding for active substances
02/10/2005WO2004092397A3 Tmprss2 regulatory sequences and uses thereof
02/10/2005WO2004092383A3 RNA INTERFERENCE MEDIATED INHIBITION OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) VIRUS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
02/10/2005WO2004087755A3 Plant haemoglobin
02/10/2005WO2004083446A3 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
02/10/2005WO2004078916A3 In vitro micro-organs, and uses related thereto
02/10/2005WO2004078112A3 Apoptosis inducing gene
02/10/2005WO2004070034A3 Oligonucleotides directed against a survivin gene and use thereof
02/10/2005WO2004069865A3 Control of plant growth and developmental processes
02/10/2005WO2004065440B1 Cationic graft-copolymer for non-viral gene delivery vector
02/10/2005WO2004065416A3 Synthetic antibody phage libraries
02/10/2005WO2004062591A3 Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases
02/10/2005WO2004058188A3 Vaccine compositions and methods
02/10/2005WO2004057941A3 RECESSIVE PLANT VIRAL RESISTANCE RESULTS FROM MUTATIONS IN TRANSLATION INITIATION FACTOR eIF4E
02/10/2005WO2004054907A3 Ftsz-polypeptides as a target for herbicidal compounds
02/10/2005WO2004053070A3 Genetic modification of carotenoid content in plants
02/10/2005WO2004048526A3 MODULATION OF HIF1α AND HIF2α EXPRESSION
02/10/2005WO2004046373A3 Promoter variants for expressing genes in a fungal cell
02/10/2005WO2004046197A3 Genes for galactomannan production in plants and methods of use
02/10/2005WO2004044139A3 Modified oligonucleotides for use in rna interference
02/10/2005WO2004043332A3 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
02/10/2005WO2004042034A3 Method for the linear amplification of complementary dna
02/10/2005WO2004039953A3 Array oligomer synthesis and use.
02/10/2005WO2004038007A3 Dna polymerases with reduced base analog detection activity
02/10/2005WO2004035774A3 Expression vectors for selection from stem cells of differentiated cardiomyocytes
02/10/2005WO2004024863A3 Adenoviral va1 pol iii expression system for rna expression
02/10/2005WO2004020589A3 The gene for a dof transcription factor capable of altering the size and stature of a plant
02/10/2005WO2004003207A9 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies
02/10/2005WO2004000015A3 Compositions and methods for improving plant performance
02/10/2005WO2003086175A8 Compositions and methods for the therapy and diagnosis of lung cancer
02/10/2005WO2003076581A3 Methods to mediate polyketide synthase module effectiveness
02/10/2005WO2003062197A3 Nek2 inhibitors
02/10/2005WO2003060065A3 Adapter-directed display system
02/10/2005WO2003050253A3 Proteins associated with cell growth, differentiation, and death
1 ... 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 ... 4023